Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Clinical Trial ID NCT02445976

PubWeight™ 3.10^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02445976

Top papers